Tango Therapeutics (TNGX) Q2 2024 Earnings

8MayConfirmed
Q2 2023
Q3 2023
Q4 2023
Q2 2024
-0.35
-0.31
-0.27
-0.23

Details

Expected EPS
-0.31
Actual EPS
-0.35
Surprise EPS
-0.04
Surprise Percent
+12.9%

Description

Tango Therapeutics (TNGX) has reported earnings of -0.35 per share for Q2 2024.

0 Comments

Share your thoughts